文献速递头颈部肿瘤放疗放疗物理与技术

动态血液剂量与头颈癌放疗临床结局的相关性

Correlation of dynamic blood dose with clinical outcomes in radiotherapy for head-and-neck cancer.
PubMed 文献 · Radiother Oncol · 2024-10-30

该研究纳入298例头颈癌患者,通过全身剂量、静态血液剂量模型和纳入血流与治疗时间的动态模型估算血液剂量,生存分析评估其与局部区域控制、无远处转移生存和总生存的相关性。多变量Cox回归显示动态血液剂量指标与临床结局存在统计学显著相关(p < 0.05),而全身剂量和静态血液剂量模型与所考虑的任何结局均不相关。

要点

  • 动态血液剂量模型与头颈癌放疗不良临床结局呈统计学显著相关(p < 0.05)。
  • 全身剂量和静态血液剂量模型与局部区域控制、无远处转移生存和总生存均不相关。
  • 动态模型纳入了血流和治疗实施时间等时间因素,使用开源计算工具HEDOS进行模拟。

核心结论

  • 动态血液剂量模型与不良临床结局之间存在统计学显著相关。

研究设计与样本

  • 研究纳入298例头颈癌患者,通过全身剂量、静态血液剂量模型和动态血液剂量模型估算血液剂量,动态模型使用开源计算工具HEDOS进行血液剂量模拟。
  • 采用生存分析评估血液剂量与局部区域控制、无远处转移生存和总生存之间的潜在相关性。

主要发现

  • 多变量Cox回归分析发现多种动态血液剂量指标与临床结局之间存在统计学显著相关(p < 0.05)。
  • 全身剂量和静态血液剂量模型与所考虑的任何结局均不相关。

关键数值与推荐

  • 动态血液剂量指标与临床结局相关性的统计学显著性阈值为p < 0.05。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Radiation-induced lymphopenia (RIL) during cancer radiotherapy is receiving growing attention due to its association with adverse clinical outcomes. Correlations between RIL and poorer locoregional control (LRC), distant-metastasis-free survival (DMFS), and overall survival (OS) have been demonstrated across multiple treatment sites. Estimates of radiation delivered to circulating blood or lymphocytes have been shown to be correlated with severe RIL. This study aims to evaluate whether blood dose estimates are equally correlated with patient outcomes directly. MATERIALS AND METHODS: For 298 head-and-neck cancer patients, blood dose was estimated via the total body dose (Dbody), a static blood dose model considering the mean dose to relevant organs and tissues (Dstatic), and a dynamic model which further included temporal aspects such as blood flow and treatment delivery time (Ddynamic). The latter utilized hematological dose (HEDOS), an open-source computational tool for blood dose simulations. Survival analysis was performed to evaluate potential correlations between blood dose and LRC, DMFS, and OS. RESULTS: Multivariable Cox regression analysis found a statistically significant (p < 0.05) correlation between various dynamic blood dose metrics and clinical outcomes. Dbody and Dstatic did not correlate with any of the outcomes considered. CONCLUSION: A statistically significant correlation between the dynamic blood dose model and adverse clinical outcomes was observed. During multivariable regression analysis, neither static blood dose model exhibited a statistically significant correlation with any of the outcomes studied.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Tattenberg S, Shin J, Höhr C, et al. Correlation of dynamic blood dose with clinical outcomes in radiotherapy for head-and-neck cancer. Radiother Oncol. 2024. PMID: 39481608. doi:10.1016/j.radonc.2024.110603

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。